Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ningmitai Capsule for CP/CPPS
NCT05890235Phase 4Completed
- Sponsor
- Guiyang Xintian Pharmaceutical Co., Ltd.
- Start
- Nov 2018
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Ningmitai Capsule in chronic prostatitis (CP) and chronic pelvic pain syndrome (CPPS) (3 arms), sponsored by Guiyang Xintian Pharmaceutical Co., Ltd. Primary endpoint: National Institutes of Health Chronic Prostatitis Symptom Index Total Score at 8 weeks. Started Nov 2018; status: completed.
02
Drugs
Ningmitai Capsule
03
Conditions
chronic prostatitis (CP)chronic pelvic pain syndrome (CPPS)
Beyond the preview
Go deeper on NCT05890235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05890235.